PULMOTECT, INC. is a bio-pharmaceutical company that develops products (host-directed/pathogen-agnostic) to reduce morbidity and mortality in patients at risk of severe respiratory diseases.
Our technology stimulates the body’s natural defenses to provide safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague).
Awards
The technology has been awarded multiple grant and equity funding awards (PI of award).
Defense Threat Reduction Agency Award under their Bacterial Rapid Acquisition Platform program
Initial Close on Series B Round in 2018
Series A Round completed in 2016
Texas Emerging Technology Fund (Dr. Scott)
NIH five year collaborative award with leading academic institutions (Dr. Hook)
U.T.M.D. Anderson Cancer Center MRP Award (Dr. Dickey)
Fannin Innovation Studio Partnership
“Living Legends” fund (Dr. Dickey)
Culpeper award (Dr. Evans)
NCI Leukemia SPORE grant (Dr. Evans)
Inaugural Texas Ignition Fund award
Lehman Brothers Foundation award (Dr. Dickey)
NHLBI R01 on mechanisms of inducible resistance (Dr. Evans)
NHLBI/Office of the Director New Innovator Award (Dr. Evans)
TJ Martell Foundation on mechanisms of inducible resistance (Dr. Evans)
U.T. M. D. Anderson Cancer Center – Technology Review Committee
Seven NIH SBIR awards (Dr. Scott)
Cancer Prevention Research Institute of Texas (Dr. Scott)
Recognition
SE Bio Investor Forum winner
Rice Alliance Conference, awarded a “Most Promising Company” award
Top three award from SBIR National Conference
World’s Best Technology Showcase presentation
Top 5 company award at the national NCET2 conference in Washington DC
Graduate Client Company of the Houston Technology Center
American Society for Cell Biology “Press Book” selection
Featured on front page of Houston Chronicle
Featured in BusinessWeek, Forbes, USNews, Washington Post and multiple other media sources
Selected to exhibit and showcase technology at the 2017 Biotechnology Innovation Organization conference
Selected to present at the 2017 Biotech Showcase conference